The role of microvessel density on the survival of patients with lung cancer: A systematic review of the literature with meta-analysis

British Journal of Cancer

Volumn 87, Issue 7, 2002, Pages 694-701

  Meert, A P ^a   Paesmans, M ^a   Martin, B ^a   Delmotte, P ^a   Berghmans, T ^a   Verdebout, J M ^a   Lafitte, J J ^b   Mascaux, C ^a   Sculier, J P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Lung cancer; Meta analysis; Microvessel count; Microvessel density

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN;

ANGIOGENESIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG TUMOR; META ANALYSIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL RATE;

EID: 0037163738     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600551     Document Type: Review

References (76)

1. Aikawa H, Takahashi S, Fujimura S, Sato M, Endo C, Sakurada A, Kondo T, Tanita T, Matsumura Y, Ono S, Saito Y, Sagawa M (1999) Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer. Anticancer Res 19: 4305-4310
2. Angeletti CA, Lucchi M, Fontanini G, Mussi A, Chella A, Ribechini A, Vignati S, Bevilacqua G (1996) Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Cancer 78: 409-415
3. Apolinario RM, van der Valk P, de Jong JS, Deville W, Ark-Otte J, Dingemans AM, van Mourik JC, Postmus PE, Pinedo HM, Giaccone G (1997) Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol 15: 2456-2466
4. Auperin A, Arriagada R, Pignon JP, Le Pechoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341: 476-484
5. Bikfalvi A, Klein S, Pintucci G, Rifkin DB (1997) Biological roles of fibroblast growth factor-2. Endocr Rev 18: 26-45
6. Cagini L, Monacelli M, Giustozzi G, Moggi L, Bellezza G, Sidoni A, Bucciarelli E, Darwish S, Ludovini V, Pistola L, Gregorc V, Tonato M (2000) Biological prognostic factors for early stage completely resected non- small cell lung cancer. J Surg Oncol 74: 53-60
7. Chandrachud LM, Pendleton N, Chisholm DM, Horan MA, Schor AM (1997) Relationship between vascularity, age and survival in non-small-cell lung cancer. Br J Cancer 76: 1367-1375
8. Cox G, Jones JL, Andi A, Waller DA, O'Byrne KJ (2001) A biological staging model for operable non-small cell lung cancer. Thorax 56: 561-566
9. Cox G, Walker RA, Andi A, Steward WP, O'Byrne KJ (2000) Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer. Lung Cancer 29: 169-177
10. D'Amico TA, Aloia TA, Moore MB, Herndon JE, Brooks KR, Lau CL, Harpole Jr DH (2000) Molecular biologic substaging of stage I lung cancer according to gender and histology. Ann Thorac Surg 69: 882-886
11. D'Amico TA, Massey M, Herndon JE, Moore M-B, Harpole DH (1999) A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thor Cardiovasc Surg 117: 736-743
12. Dazzi C, Cariello A, Maioli P, Solaini L, Scarpi E, Rosti G, Lanzanova G, Marangolo M (1999) Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer. Lung Cancer 24: 81-88
13. de Jong JS, van Diest PJ, Baak JP (1995) Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 73: 922-926
14. Duarte IG, Bufkin BL, Pennington MF, Gal AA, Cohen C, Kosinski AS, Mansour KA, Miller JI (1998) Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J Thor Cardiovasc Surg 115: 652-659
15. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G (1997) Language bias in randomised controlled trials published in English and German. Lancet 350: 326-329
16. Ferrara N (2000) VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11: 617-624
17. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
18. Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, Chinè S, Angeletti CA, Harris AL, Bevilacqua G (1995) Microvessel count Predicts metastatic disease and survival in non-small cell lung cancer. J Pathol 117: 57-63
19. Fontanini G, Boldrini L, Vignati S, Chinè S, Basolo F, Silvestri V, Lucchi M, Mussi A, Angeletti CA, Bevilacqua G (1998a) Bcl2 and p53 Regulate Vascular Endothelial growth Factor (VEGF)-mediated Angiogenesis in Non-small Cell Lung Carcinoma. Eur J Cancer 34: 718-723
20. Fontanini G, De Laurentis M, Vignati S, Chinè S, Lucchi M, Silvestri V, Mussi A, De Placido S, Tortora P, Raffaele Bianco A, Gullick W, Angeletti CA, Bevilacqua G, Ciardello F (1998b) Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res 4: 241-249
21. Fontanini G, Lucchi M, Vignati S, Mussi A, Ciardello F, De Laurentis M, De Placido S, Basolo F, Angeletti CA, Bevilacqua G (1997a) Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst 89: 881-886
22. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Chinè S, Angeletti CA, Bevilacqua G (1996) Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. Clin Cancer Res 2: 1067-1075
23. Fontanini G, Vignati S, Lucchi M, Mussi A, Calcinai A, Boldrini L, Chinè S, Silvestri V, Angeletti CA, Basolo F, Bevilacqua G (1997b) Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer 75: 1295-1301
24. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177: 275-283
25. Giatromanolaki A, Koukourakis MI, O'Byrne KJ, Fox S, Whitehouse RM, Talbot DC, Harris AL, Gatter KC (1996a) Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 179: 80-88
26. Giatromanolaki A, Koukourakis MI, O'Byrne KJ, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse RM, Harris AL, Gatter KC (1996b) Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. Anticancer Res 16: 3819-3826
27. Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Cox G, Thorpe PE, Gatter KC, Harris AL (2000a) Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways. Clin Cancer Res 6: 1917-1921
28. Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Gatter KC, Harris AL (2000b) 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol 192: 140-149
29. Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC (1997) Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin Cancer Res 3: 2485-2492
30. Han H, Silverman JF, Santucci TS, Macherey RS, d'Amato TA, Tung MY, Weyant RJ, Landreneau RJ (2001) Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol 8: 72-79
31. Harpole DH, Richards WG, Herndon JE, Sugarbaker DJ (1996) Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg 61: 1470-1476
32. Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K (2001) Transforming growth factor-betal level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91: 964-971
33. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124
34. Imoto H, Osaki T, Taga S, Ohgami A, Ichiyoshi Y, Yasumoto K (1998) Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thor Cardiovasc Surg 115: 1007-1014
35. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562
36. Kakolyris S, Giatromanolaki A, Koukourakis MI, Leigh IM, Georgoulias V, Kanavaros P, Sivridis E, Gatter KC, Harris AL (1999) Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression. Cancer Res 59: 5602-5607
37. Kanters SD, Lammers JW, Voest EE (1995) Molecular and biological factors in the prognosis of non-small cell lung cancer. Eur Respir J 8: 1389-1397
38. Kawaguchi T, Yamamoto S, Kudoh S, Goto K, Wakasa K, Sakurai M (1997) Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma. Anticancer Res 17: 3743-3746
39. Koukourakis MI (2001) Tumour angiogenesis and response to radiotherapy. Anticancer Res 21(6B): 4285-4300
40. Koukourakis MI, Giatromanolaki A, Guddo F, Kaklamanis L, Vignola M, Kakolyris S, Turley H, Georgoulias V, Bonsignore G, Gatter KC, Harris AL (2000a) c-erbB-2 and episialin challenges host immune response by HLA class I expression in human non-small-cell lung cancer. J Immunother 23: 104-114
41. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Cox J, Krammer B, Gatter KC, Harris AL (1999) bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer. Clin Exp Metastasis 17: 545-554
42. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Whitehouse RM, Talbot DC, Gatter KC, Harris AL (1997) Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer. Int J Cancer 74: 565-570
43. Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL (2000b) Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res 60: 3088-3095
44. Liao M, Wang H, Lin Z, Feng J, Zhu D (2001) Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. Lung Cancer 33: 125-132
45. Lucchi M, Fontanini G, Mussi A, Vignati S, Ribechini A, Menconi GF, Bevilacqua G, Angeletti CA (1997) Tumor angiogenesis and biologic markers in resected stage I NSCLC. Eur J Cardio-thor Surg 12: 535-541
46. Macchiarini P, Fontanini G, Dulmet E, de Montpreville V, Chapelier AR, Cerrina J, Le Roy Ladurie F, Dartevelle PG (1994) Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracic inlet. Ann Thorac Surg 57: 1534-1539
47. Martin L, Green B, Renshaw C, Lowe D, Rudland P, Leinster SJ, Winstanley J (1997) Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer 76: 1046-1054
48. Matsuyama K, Chiba Y, Sasaki M, Tanaka H, Muraoka R, Tanigawa N (1998) Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. Ann Thorac Surg 65: 1405-1409
49. Mattern J (2001) Role of angiogenesis in drug resistance. Anticancer Res 21(6B): 4265-4270
50. Mattern J, Koomägi R, Volm M (1995) Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int J Oncology 6: 1059-1062
51. Meert AP, Berghmans T, Branle F, Lemaitre F, Mascaux C, Rubesova E, Vermylen P, Paesmans M, Sculier JP (1999) Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment. Anticancer Res 19: 4379-4390
52. Meert AP, Paesmans M, Berghmans T, Martin B, Mascaux C, Vallot F, Verdebout JM, Lafitte JJ, Sculier JP (2001) Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 1: 5
53. Mulrow CD (1987) The medical review article: state of the science. Ann Intern Med 106: 485-488
54. O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL (2000) Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 82: 1427-1432
55. Offersen BV, Pfeiffer P, Hamilton-Dutoit S, Overgaard J (2001) Patterns of angiogenesis in nonsmall-cell lung carcinoma. Cancer 91: 1500-1509
56. Ohta Y, Tomita Y, Oda M, Watanabe S, Murakami S, Watanabe Y (1999) Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. Ann Thorac Surg 68: 1034-1038
57. Paesmans M, Sculier JP (1998) Les facteurs pronostiques. In: Cancers bronchopulmonaires, Milleron B, Depierre A (eds). pp 239-247. Arnette: Vélizy-Villacoublay
58. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-2834
59. Pastorino U, Andreola S, Tagliabue E, Pezella F, Incarbone E, Sozzi G, Buyse M, Menard S, Pierotti M, Rilke F (1997) Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncology 15: 2858-2865
60. Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson M, Ogden GR, Schor SL, Schor AM (1997) The association between tumour progression and vascularity in the oral mucosa. J Pathol 183: 39-43
61. Sheng HY, Aoe M, Doihara H, Andou A, Shimizu N (2000) Prognostic value of vascular endothelial growth factor expression in primary lung carcinoma. Acta Med Okayama 54: 119-126
62. Shibusa T, Shijubo N, Abe S (1998) Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res 4: 1483-1487
63. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP (2001) Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 18: 705-719
64. Stewart LA, Parmar MK (1993) Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 341: 418-422
65. Strauss GM (1997) Prognostic markers in resectable non-small cell lung cancer. Oncol Clin North Am 11: 409-434
66. Takanami I, Takeuchi K, Kodaira S (1999) Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57: 138-142
67. Takanami I, Takeuchi K, Naruke M (2000) Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88: 2686-2692
68. Takanami I, Tanaka F, Hashizume T, Kodaira S (1997) Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival. Neoplasma 44: 295-298
69. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R, Iki M (1996) Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56: 2671-2676
70. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY (1996) Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-2484
71. Vermeulen PB, Libura M, Libura J, O'Neill PJ, van Dam P, Van Marck E, Van Oosterom AT, Dirix LY (1997) Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Res Treat 42: 165-172
72. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887
73. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
74. Yamazaki K, Abe S, Takewara H, Sukoh N, Watanabe N, Ogura S, Nakajima I, Isobe H, Inoue K, Kawakami Y (1994) Tumor angiogenesis in human lung adenocarcinoma. Cancer 74: 2245-2250
75. Yano T, Tanikawa S, Fujie T, Masutani M, Horie T (2000) Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer. Eur J Cancer 36: 601-609
76. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27: 335-371